Several clinical trials are testing new ways to manage Parkinson's symptoms -- from anxiety to constipation to dementia -- but they need volunteers to help assess the safety and efficacy of these treatments.
Learn more about volunteering for studies with our Trial Participant Pack.
Click through to learn more about each of these trials on our Fox Trial Finder site. You can always browse our Trial Finder for information on even more clinical trials testing new therapies as well as observational studies designed to increase our understanding of Parkinson's disease.
What: Testing the anti-anxiety drug buspirone for its safety and efficacy in people with Parkinson's disease
Who: People with Parkinson's disease and significant anxiety
Where: University of Rochester, New York
LY3154207 for Parkinson's Disease Dementia
What: Evaluating a compound to treat memory and thinking changes -- such as difficulty concentrating or decision-making -- that interfere with daily activities and quality of life
Who: People with Parkinson's for at least two years who experience memory or thinking changes that interfere with daily activities and who have a care partner who can attend appointments with them
Where: This trial is taking place at more than 60 sites in 28 states and the District of Columbia, as well as two sites in Toronto and four in Puerto Rico. Visit the Fox Trial Finder listing for a complete list of sites and contact information, or call 1-877-CTLILLY (1-877-285-4559).
Rehabilitation Treatment for Airway Protection
What: Evaluating a strengthening program and sensorimotor treatment to improve swallowing and coughing to help keep the airway clear and avoid serious infection
Who: People with Parkinson's who have difficulty swallowing
Where: University of Florida, Gainesville
What: Testing a new drug compound to treat constipation and slow stomach emptying associated with Parkinson's disease
Who: People with early to moderate-stage Parkinson's disease with constipation; participants may be on Parkinson's medication or have had deep brain stimulation
Where: Virginia Commonwealth University, Richmond
SEP-363856 for Parkinson's Psychosis
What: Studying a new drug to treat hallucinations and delusions with Parkinson's disease
Who: People over age 55 with Parkinson's psychosis who have a care partner who can attend appointments with them
Where: This trial is taking place at 12 sites across seven states. Visit the Fox Trial Finder listing for a complete list of sites.
